Our latest review “Radiotheranostics in oncology: current challenges and emerging opportunities” now out in NRCO. What a privilege to work with some of the greats Lisa Bodei, MD, PhD Ken Herrmann Profs Andrew Scott and Heiko Schoder on this! rdcu.be/cP2qf

PPP and RECIP 1.0 are reliable criteria for treatment response evaluation in men with metastatic castration-resistant #ProstateCancer. Among 5 criteria tested, #RECIP achieved highest prognostic value and highest inter-reader reliability. #PSMA #EJNMMI link.springer.com/article/10.100…

Great talk from Ken Herrmann about synergies between Radioisotopes Therapy and Systemic Therapy #EAU22 Ken Herrmann

Another outstanding presentation by prof. Stefano Fanti #EAU22. Special thanks to our friends from EAU for this excellent joint session.

In the long-run the future is created by the hard working optimists.

Inaugaural Gordon Research Conference on Radionuclide Theranostics for the Management of Cancer in beautiful Maime. Great place! Great speakers. Great discussions. Thanks to the organizers and speakers. Radionuclide Theranostics in Cancer: GRC 2022 Elcin Zan Ebrahim Delpassand Josh Mailman Katharina Lueckerath

Happy to share our comment on ENACT authors.elsevier.com/c/1fYld14kplrK…

This is the best definition of ‘focus’ x.com/ricburton/stat…

#RECIP

#RECIP cited at #EANM2022. RECIP 1.0 showed superior accuracy compared to other criteria in evaluating response during Lu-PSMA.

Congrats to James Buteau Michael Hofman for this incredible work! PSMA uptake on baseline PET imaging is a predictive biomarker for Lu-PSMA.

Do not use your energy to worry. Use your energy to believe, to create, to learn, to think and to grow.

The Prostate Cancer Foundation PCF Science Young Investigator Program is one of our greatest assets, each year deploying a new generation in the fight against #ProstateCancer .

#RECIP criteria were validated on an independent patient cohort. End-of-treatment PSMA-PET/CT after 177Lu-PSMA is prognostic for OS after 177Lu-PSMA. Infographic of original #RECIP study below! JNM PCF Science

So grateful to visit Michael Hofman and the amazing team at Peter Mac Cancer Centre Nuclear Medicine. PCF Science Howard Soule. Unique collaboration of @HopkinsNucs!

🌟Introducing PROMISE 2 for standardized evaluation of PSMA PET/CT! 📄Unlock the full potential for clinical routine & research 🔍🎯 Improve accuracy & consistency💪 #PSMA authors.elsevier.com/sd/article/S03… European Association of Urology (EAU)

Excellent work by liljasol and her team Johns Hopkins Medicine to explore imaging biomarkers of neurodegenerative diseases. Moe Sadaghiani pubmed.ncbi.nlm.nih.gov/37378737/

Superb work using AI for automatic treatment response evaluation in prostate cancer. #RECIP validated in early stage prostate cancer in patients with BCR and low tumor burden. link.springer.com/article/10.100…

100 years of the fundamental principle of #nuclearmedicine and #molecularimaging. pubmed.ncbi.nlm.nih.gov/37884328/ Andrei Gafita SNMMI JNM

Congratulations to our fantastic team at Johns Hopkins Theranostics Center for being recognized by SNMMI a Therapy Center of Excellence! liljasol Avery Spitz MSN RN Danielle Rill Jeffrey Young Johns Hopkins Radiology